Aptose Biosciences

APTO52

Penny Stock

$0.39arrow_drop_down1.50%-$0.00

Penny Stock

APTO52

$0.39

arrow_drop_down1.50%-$0.00

Penny Stock

Performance History

Key Stats
Open	$0.36
Prev. Close	$0.36
EPS	-4.24
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$7.21M
PE Ratio	-

	LOW	HIGH
Day Range	0.36	0.39
52 Week Range	0.33	3.32

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-4.24

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Aptose Biosciences (APTO)

Aptose Biosciences Inc (APTO) is a biotechnology company specializing in the discovery and development of targeted therapies to treat cancer. The company focuses on developing small molecule drugs that selectively target and inhibit specific cancer-causing proteins to halt tumor growth and improve patient outcomes. Aptose Biosciences has a strong pipeline of drug candidates with the potential to address a range of cancer types, including hematologic malignancies and solid tumors.

APTO has a rich stock price history, which can provide valuable insights for investors. By analyzing the historical performance of the stock, investors can gain a better understanding of its potential future performance. The stock has experienced fluctuations over the years, with periods of both growth and decline. It is important for investors to carefully analyze the factors that have influenced the stock's performance in the past and evaluate whether those factors are likely to continue to impact its performance in the future.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. William G. Rice Ph.D.
Headquarters: Toronto
Employees: 35
Exchange: NASDAQ

Keep an eye on Aptose Biosciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Aptose Biosciences 's (APTO) price per share?

The current price per share for Aptose Biosciences (APTO) is $0.4. The stock has seen a price change of -$0.01 recently, indicating a -1.5% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Aptose Biosciences (APTO)?

For Aptose Biosciences (APTO), the 52-week high is $3.32, which is 738.17% from the current price. The 52-week low is $0.33, the current price is 20.03% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Aptose Biosciences (APTO) a growth stock?

Aptose Biosciences (APTO) has shown an average price growth of -3.92% over the past three years. It has received a score of -4 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Aptose Biosciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Aptose Biosciences (APTO) stock price performance year to date (YTD)?

As of the latest data, Aptose Biosciences (APTO) has a year-to-date price change of -83.36%. Over the past month, the stock has experienced a price change of -4.42%. Over the last three months, the change has been -36.05%. Over the past six months, the figure is -67.8%. Looking at a longer horizon, the five-year price change stands at -98.71%.

help

Is Aptose Biosciences (APTO) a profitable company?

Aptose Biosciences (APTO) has a net income of -$52.15M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$52.36M. Furthermore, the EBITDA is -$40.85M.

help

What is the market capitalization of Aptose Biosciences (APTO)?

Aptose Biosciences (APTO) has a market capitalization of $7.22M. The average daily trading volume is 0.39, indicating the stock's liquidity and investor engagement.

News

Aptose Receives $10 Million Through a Facility Agreement with Hanmi; Negotiating Future Collaboration Agreement with Hanmi to Jointly Develop Tuspetinib

APTOSE BIOSCIENCES

HANMI PHARMACEUTICAL

TUSPETINIB

ACUTE MYELOID LEUKEMIA

Aug 30, 2024

Aptose Receives $10 Million Through a Facility Agreement with Hanmi; Negotiating Future Collaboration Agreement with Hanmi to Jointly Develop Tuspetinib